Trial Profile
Peripheral Modulation of Muscle Stiffness and Spasticity
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2023
Price :
$35
*
At a glance
- Drugs Hyaluronidase (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- 29 Nov 2023 Planned End Date changed from 16 Nov 2023 to 16 Nov 2024.
- 29 Nov 2023 Planned primary completion date changed from 16 Nov 2023 to 16 Nov 2024.
- 07 Oct 2021 Status changed from not yet recruiting to recruiting.